Triple

T9807213
Position Surface form Disambiguated ID Type / Status
Subject Pharmaceuticals Division E238182 entity
Predicate coreBusinessUnitOf P7588 FINISHED
Object Roche Group E46707 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Roche Group | Statement: [Pharmaceuticals Division, coreBusinessUnitOf, Roche Group]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Roche Group
Context triple: [Pharmaceuticals Division, coreBusinessUnitOf, Roche Group]
  • A. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • B. Roche chosen
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • C. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • D. Sanofi
    Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
  • E. Schering
    Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: coreBusinessUnitOf
Context triple: [Pharmaceuticals Division, coreBusinessUnitOf, Roche Group]
  • A. hasBusinessDivision chosen
    Indicates that an organization includes or is composed of a specific business division as a subordinate unit.
  • B. primaryBusinessArea
    Indicates the main field, sector, or domain in which an entity primarily conducts its business activities.
  • C. managementUnitOf
    Indicates that one entity serves as the administrative or managerial unit responsible for overseeing or controlling another entity.
  • D. coreUnitType
    Indicates that one entity is classified as the primary or fundamental type/category to which another entity (a core unit) belongs.
  • E. formerCoreBusiness
    Indicates that an entity was previously the main or primary line of business for another entity but no longer holds that status.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca84defac48190abc1148804f184c1 completed March 30, 2026, 2:12 p.m.
NER Named-entity recognition batch_69cdab7cb9588190953a063cb7b9e29e completed April 1, 2026, 11:34 p.m.
NED1 Entity disambiguation (via context triple) batch_69d74fb63b7081909cb6faddd795ced6 completed April 9, 2026, 7:05 a.m.
PD Predicate disambiguation batch_69cd03dd2da881909052fbf29736a773 completed April 1, 2026, 11:39 a.m.
Created at: March 30, 2026, 8:29 p.m.